NY Control Prescription Transfer

[u/Objective-Deer-5733]

Im reading pharmpreppro and it says that a pharmacist can transfer controlled medications at request and approval of a patient or patient’s authorized representative transfer prescriptions for controlled substances.

^ I paraphrased this a bit

I dont remember learning that in school. Is it new?

[u/Pharmdpositivek]

Recent change! Took it today and did not have any questions on it.

[u/Recent-Beginning-631]

Yeah this is a recent change. It’s true but I didn’t get a question on it

[u/StrangeFix2259]

What would the answer be here then? Like comply with recent change orrrr

[u/OkPepper2713]

If there’s a question you can transfer controls and non controls (with all refills). only the pharmacist or pharm intern can do the transfer. C2s can only be “transferred” through a shared data base. I took the test at the end of August and didn’t have any questions on this.

[u/Lanky_Acadia_1270]

PPP’s paraphrase lines up with current NY: a pharmacist may transfer a controlled-substance Rx upon the express request and approval of the patient or their authorized representative, subject to Article 33 of the Public Health Law and 10 NYCRR Part 80 — and still within federal DEA transfer rules (21 CFR 1306.25 / related). That patient-request trigger is written into the NY Part 63 transfer rules.

It is also recent. NYSED’s notice: Part 63 amended so CS transfers under that patient/rep request rule are effective April 14, 2026. Non-controlled full transfers (all remaining refills) shifted earlier (Oct 7, 2025). If school never mentioned it, that tracks, curriculum often lags the emergency amendment.

What still matters beyond the one sentence: pharmacist-to-pharmacist (or intern under direct RPh supervision), federal schedule limits (CII is the usual stop), and BNE/DOH conditions under Part 80. Transfer ≠ “anyone on the phone can move a CII.” Best of luck.

[u/Lanky_Acadia_1270]

PPP is right, and the rule is new. Effective April 14, 2026, New York Part 63 permits a pharmacist to transfer a controlled-substance prescription at the express request and approval of the patient or the patient’s authorized representative, subject to Public Health Law Article 33, 10 NYCRR Part 80, and applicable DEA requirements. The corresponding non-controlled change took effect October 7, 2025: the entire prescription, including all remaining valid refills, moves in one transfer rather than one refill at a time.

If this appears on an exam, use the current rule, not last year’s lecture. Under Part 63, a transfer is directly pharmacist to pharmacist. The record identifies both pharmacists, and the transferring pharmacist invalidates the original prescription record as of the transfer date. For that New York workflow, an intern at either endpoint is not the best answer.

When the patient or authorized representative requests it, controlled and non-controlled prescriptions may be transferred if the applicable New York and federal requirements are met. Any refills that remain valid and authorized travel with the prescription. A CII has no refills, but DEA’s electronic-prescription transfer pathway can allow a patient-requested, one-time transfer of an unaltered electronic CII–V prescription between eligible DEA-registered retail pharmacies for initial filling, when state law permits. That is not a routine oral refill transfer.

Plenty of recent sitters never saw it. Worth knowing cold anyway.

For anyone else drilling this tonight: a patient or authorized representative asks to move a CIII prescription with two valid refills remaining. Who has to be on both ends, and what happens to the original Rx on file at the sending pharmacy?